- Home
- Publications
- Publication Search
- Publication Details
Title
Research progress of interleukin-15 in cancer immunotherapy
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2023-05-12
DOI
10.3389/fphar.2023.1184703
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Heterodimeric IL-15 (hetIL-15) reduces circulating tumor cells and metastasis formation improving chemotherapy and surgery in 4T1 mouse model of TNBC
- (2023) Vasiliki Stravokefalou et al. Frontiers in Immunology
- IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation
- (2023) Madhuparna Nandi et al. Cancers
- Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice
- (2023) Niraj Shrestha et al. AGING CELL
- IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM
- (2023) Markella Zannikou et al. Journal for ImmunoTherapy of Cancer
- Protein Signatures and Individual Circulating Proteins, including IL-6 and IL-15, Associated with Prognosis in Patients with Biliary Tract Cancer
- (2023) Troels D. Christensen et al. Cancers
- Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells
- (2022) Pallavi Chaturvedi et al. MOLECULAR THERAPY
- Harnessing cytokines and chemokines for cancer therapy
- (2022) David J. Propper et al. Nature Reviews Clinical Oncology
- Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
- (2022) Melissa M. Berrien-Elliott et al. Science Translational Medicine
- Interleukins and Ischemic Stroke
- (2022) Hua Zhu et al. Frontiers in Immunology
- IL-15 Participates in the Pathogenesis of Polycystic Ovary Syndrome by Affecting the Activity of Granulosa Cells
- (2022) Yan Liu et al. Frontiers in Endocrinology
- A very long-acting IL-15: implications for the immunotherapy of cancer
- (2022) John A Hangasky et al. Journal for ImmunoTherapy of Cancer
- Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
- (2022) Emma Kurz et al. CANCER CELL
- Interleukin 15 in Cell-Based Cancer Immunotherapy
- (2022) Yang Zhou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of response
- (2022) Robert B Rebhun et al. Journal for ImmunoTherapy of Cancer
- Improving NK Cell Function in Multiple Myeloma with NKTR-255, a Novel Polymer-Conjugated Human IL-15
- (2022) Rafael Alonso Fernández et al. Blood Advances
- Peptide vaccine from cancer-testis antigen ODF2 can potentiate the cytotoxic T lymphocyte infiltration through IL-15 in non-MSI-H colorectal cancer
- (2022) Ranran Shi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The tumor microenvironment drives NK cell metabolic dysfunction leading to impaired antitumor activity
- (2022) Nicola Tumino et al. INTERNATIONAL JOURNAL OF CANCER
- A novel antibody-interleukin-15 fusion protein selectively localizes to tumors, synergizes with TNF-based immunocytokine and inhibits metastasis
- (2021) Riccardo Corbellari et al. MOLECULAR CANCER THERAPEUTICS
- Heterodimeric IL-15 in Cancer Immunotherapy
- (2021) Cristina Bergamaschi et al. Cancers
- NKTR-255, a novel polymer-conjugated rhIL-15 with potent antitumor efficacy
- (2021) Takahiro Miyazaki et al. Journal for ImmunoTherapy of Cancer
- CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment
- (2021) Mauro Di Pilato et al. CELL
- Tumor-conditional IL-15 pro-cytokine reactivates anti-tumor immunity with limited toxicity
- (2021) Jingya Guo et al. CELL RESEARCH
- Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignancies
- (2021) Nina Shah et al. Future Oncology
- Interleukin-15 modulates the response of cortical neurons to ischemia
- (2021) Vien Nguyen et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Bifunctional TGF-β trap/IL-15 protein complex elicits potent NK cell and CD8+ T cell immunity against solid tumors
- (2021) Bai Liu et al. MOLECULAR THERAPY
- An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
- (2021) Yuanming Xu et al. Cancer Immunology Research
- A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy
- (2021) Michelle K. Becker-Hapak et al. Cancer Immunology Research
- Engineered Interleukin-15 Autocrine Signaling Invigorates Anti-CD123 CAR-NK Cells
- (2021) Ilias Christodoulou et al. BLOOD
- Donor Memory-like NK cells Persist and Induce Remissions in Pediatric Patients with Relapsed AML after Transplant
- (2021) Jeffrey J Bednarski et al. BLOOD
- Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
- (2021) Lukas Kraehenbuehl et al. Nature Reviews Clinical Oncology
- Cytokine-induced memory-like natural killer cells for cancer immunotherapy
- (2021) Mubin Tarannum et al. Stem Cell Research & Therapy
- Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
- (2021) Kevin Conlon et al. Journal for ImmunoTherapy of Cancer
- Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities
- (2021) Ilias Christodoulou et al. Journal for ImmunoTherapy of Cancer
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- IL-15 in the Combination Immunotherapy of Cancer
- (2020) Thomas A. Waldmann et al. Frontiers in Immunology
- Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10
- (2020) Cristina Bergamaschi et al. Journal for ImmunoTherapy of Cancer
- IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment
- (2020) Mélanie Desbois et al. Journal for ImmunoTherapy of Cancer
- Innate and Innate-Like Cells: The Future of Chimeric Antigen Receptor (CAR) Cell Therapy
- (2020) Diana Cortés-Selva et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy
- (2020) Ying Yang et al. Cancers
- Biological effects of IL-15 on immune cells and its potential for the treatment of cancer
- (2020) Shuling Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- IL-15-mediated reduction of mTORC1 activity preserves the stem cell memory phenotype of CAR-T cells and confers superior antitumor activity
- (2019) Darya Alizadeh et al. Cancer Immunology Research
- IL-15 by continuous i.v. infusion to adult patients with solid tumors in a Phase I trial induced dramatic NK cell subset expansion
- (2019) Kevin C Conlon et al. CLINICAL CANCER RESEARCH
- The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
- (2019) Warren J. Leonard et al. IMMUNITY
- Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer
- (2019) Thomas A. Waldmann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Control of memory CD8+ T cell longevity and effector functions by IL-15
- (2019) Jeffrey C. Nolz et al. MOLECULAR IMMUNOLOGY
- First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
- (2018) Rizwan Romee et al. BLOOD
- An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression
- (2018) Rika Fujii et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
- (2018) John M Wrangle et al. LANCET ONCOLOGY
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy
- (2018) Qiyue Hu et al. Scientific Reports
- IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages
- (2018) Meili Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels
- (2017) James N. Kochenderfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Interleukin-15 in obesity and metabolic dysfunction: current understanding and future perspectives
- (2017) Y. Duan et al. Obesity Reviews
- IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation
- (2017) Johan MJ Van den Bergh et al. PHARMACOLOGY & THERAPEUTICS
- Cytokines in Cancer Immunotherapy
- (2017) Thomas A. Waldmann Cold Spring Harbor Perspectives in Biology
- Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants
- (2017) Giedre Krenciute et al. Cancer Immunology Research
- Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion
- (2016) Sinnie Sin Man Ng et al. CLINICAL CANCER RESEARCH
- IL-15Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists
- (2016) Mélanie Desbois et al. JOURNAL OF IMMUNOLOGY
- Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
- (2016) Lenka V. Hurton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies
- (2016) Nathan Singh et al. Science Translational Medicine
- Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
- (2015) Kevin C. Conlon et al. JOURNAL OF CLINICAL ONCOLOGY
- The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy
- (2015) T. A. Waldmann Cancer Immunology Research
- The Absence or Overexpression of IL-15 Drastically Alters Breast Cancer Metastasis via Effects on NK Cells, CD4 T Cells, and Macrophages
- (2014) Amy Gillgrass et al. JOURNAL OF IMMUNOLOGY
- Beneficial metabolic activities of inflammatory cytokine interleukin 15 in obesity and type 2 diabetes
- (2014) Jianping Ye Frontiers of Medicine
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- Characterization and Favorablein VivoProperties of Heterodimeric Soluble IL-15·IL-15Rα Cytokine Compared to IL-15 Monomer
- (2013) Elena Chertova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+T cells into innate-like effector cells with antitumor activity
- (2013) Hing C Wong et al. OncoImmunology
- Cytokine activation induces human memory-like NK cells
- (2012) R. Romee et al. BLOOD
- IL-15 Overexpression Promotes Endurance, Oxidative Energy Metabolism, and Muscle PPARδ, SIRT1, PGC-1α, and PGC-1β Expression in Male Mice
- (2012) LeBris S. Quinn et al. ENDOCRINOLOGY
- Mechanistic and structural insight into the functional dichotomy between IL-2 and IL-15
- (2012) Aaron M Ring et al. NATURE IMMUNOLOGY
- Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
- (2011) T. A. Waldmann et al. BLOOD
- IL-15:IL-15 receptor alpha superagonist complex: High-level co-expression in recombinant mammalian cells, purification and characterization
- (2011) Kai-ping Han et al. CYTOKINE
- Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
- (2010) V Hoyos et al. LEUKEMIA
- Macrophage- and Dendritic-Cell-Derived Interleukin-15 Receptor Alpha Supports Homeostasis of Distinct CD8+ T Cell Subsets
- (2009) Erwan Mortier et al. IMMUNITY
- Interleukin-15 combined with an anti-CD40 antibody provides enhanced therapeutic efficacy for murine models of colon cancer
- (2009) M. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
- (2008) Nicholas D. Huntington et al. JOURNAL OF EXPERIMENTAL MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search